AAPL 258.8189 0.2397% MSFT 439.14 -0.0432% NVDA 140.185 -0.025% GOOGL 196.0128 -0.0496% GOOG 197.54 -0.0152% AMZN 227.87 -0.5152% META 603.74 -0.6598% AVGO 245.6915 2.5081% TSLA 452.9125 -2.0264% TSM 204.19 -1.0372% LLY 797.2122 0.1938% V 320.96 0.0967% JPM 242.37 0.0248% UNH 509.62 0.6955% NVO 87.85 0.5494% WMT 92.38 -0.3237% LVMUY 132.91 0.4459% XOM 106.31 -0.0846% LVMHF 664.0 0.9119% MA 536.2159 0.0944%
Last update at 2024-12-26T18:50:00Z
Does This Rumor Make Walgreens Boots Alliance Stock a Buy?
Sun 15 Dec 24, 12:00 AMIs Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
Thu 05 Dec 24, 12:00 AMShould You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Tue 26 Nov 24, 12:00 AM3 of the Scariest Stocks to Be Holding Right Now
Thu 31 Oct 24, 12:00 AMWhy Investors Were Bailing Out of Walgreens Boots Alliance This Week
Fri 25 Oct 24, 12:00 AMIs Walgreens Boots Alliance Stock a Buy After Having Its Best Day in Years?
Thu 24 Oct 24, 12:00 AMWhy Walgreens Boots Alliance Plunged Again Today
Tue 22 Oct 24, 12:00 AMAlpine Income Property Trust Inc (PINE) Q3 2024 Earnings Call Highlights: Strong Earnings ...
Sat 19 Oct 24, 07:02 AM2 "Safe" Healthcare Stocks That Are Anything But
Sat 19 Oct 24, 12:00 AM| Breakdown | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Income before tax | -5419.00000M | 3985.00M | 1995.00M | 743.00M | 4527.00M |
| Minority interest | 448.00M | 271.00M | 319.00M | -32.00000M | -20.00000M |
| Net income | -3080.00000M | 4337.00M | 1328.00M | 456.00M | 3982.00M |
| Selling general administrative | 34205.00M | 27295.00M | 24586.00M | 27045.00M | 25242.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 27072.00M | 28266.00M | 28067.00M | 28017.00M | 30076.00M |
| Reconciled depreciation | 2257.00M | 1990.00M | 1973.00M | 1927.00M | 2038.00M |
| Ebit | -4839.00000M | 4385.00M | 3481.00M | 1312.00M | 4998.00M |
| Ebitda | -2582.00000M | 6375.00M | 5454.00M | 3309.00M | 7269.00M |
| Depreciation and amortization | 2257.00M | 1990.00M | 1973.00M | 1997.00M | 2271.00M |
| Non operating income net other | - | 2998.00M | 558.00M | 70.00M | 233.00M |
| Operating income | -6882.00000M | 4385.00M | 3481.00M | 1312.00M | 4998.00M |
| Other operating expenses | 146214.00M | 131732.00M | 129028.00M | 138565.00M | 132032.00M |
| Interest expense | 580.00M | 400.00M | 905.00M | 639.00M | 704.00M |
| Tax provision | -1858.00000M | -30.00000M | 667.00M | 360.00M | 588.00M |
| Interest income | - | - | - | 627.00M | 549.00M |
| Net interest income | -580.00000M | -400.00000M | -905.00000M | -639.00000M | -704.00000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -1858.00000M | -30.00000M | 667.00M | 360.00M | 588.00M |
| Total revenue | 139081.00M | 132703.00M | 132509.00M | 139537.00M | 136866.00M |
| Total operating expenses | 34205.00M | 27295.00M | 24586.00M | 27045.00M | 25242.00M |
| Cost of revenue | 112009.00M | 104437.00M | 104442.00M | 111520.00M | 106790.00M |
| Total other income expense net | 2295.00M | -400.00000M | -1486.00000M | -569.00000M | -471.00000M |
| Discontinued operations | - | - | 548.00M | 548.00M | 548.00M |
| Net income from continuing ops | -3528.00000M | 4065.00M | 1955.00M | 383.00M | 3939.00M |
| Net income applicable to common shares | -3080.00000M | 4337.00M | 2542.00M | 456.00M | 3982.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Total assets | 96628.00M | 90124.00M | 81285.00M | 87174.00M | 68239.00M |
| Intangible assets | 13635.00M | 10730.00M | 9936.00M | 10753.00M | 10876.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1126.00M | 1060.00M | 799.00M | 974.00M | 1118.00M |
| Total liab | 68138.00M | 59716.00M | 57463.00M | 66038.00M | 43446.00M |
| Total stockholder equity | 20021.00M | 29366.00M | 23822.00M | 21136.00M | 24152.00M |
| Deferred long term liab | - | 1442.00M | 1850.00M | 1498.00M | 1785.00M |
| Other current liab | 8635.00M | 7983.00M | -1.00000M | -1.00000M | 5690.00M |
| Common stock | 12.00M | 12.00M | 12.00M | 12.00M | 12.00M |
| Capital stock | 12.00M | 12.00M | 12.00M | 12.00M | 12.00M |
| Retained earnings | 33058.00M | 37801.00M | 35121.00M | 34210.00M | 35815.00M |
| Other liab | 12416.00M | 5001.00M | 5262.00M | 3750.00M | 5254.00M |
| Good will | 28187.00M | 22280.00M | 12421.00M | 15268.00M | 16560.00M |
| Other assets | 2524.00M | 1729.00M | 1987.00M | 660.00M | 640.00M |
| Cash | 728.00M | 1358.00M | 1193.00M | 516.00M | 1023.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 24535.00M | 22583.00M | 22054.00M | 27070.00M | 25769.00M |
| Current deferred revenue | - | - | 7355.00M | 6649.00M | - |
| Net debt | 32806.00M | 34119.00M | 32199.00M | 39624.00M | 15813.00M |
| Short term debt | 3265.00M | 3345.00M | 3564.00M | 5964.00M | 5738.00M |
| Short long term debt | 918.00M | 1059.00M | 1306.00M | 3539.00M | 5738.00M |
| Short long term debt total | 33534.00M | 35477.00M | 33392.00M | 40140.00M | 16836.00M |
| Other stockholder equity | -10056.00000M | -5642.00000M | -9202.00000M | -9315.00000M | -7778.00000M |
| Property plant equipment | 31754.00M | 32988.00M | 34140.00M | 33351.00M | 13478.00M |
| Total current assets | 15503.00M | 16902.00M | 15814.00M | 18073.00M | 18700.00M |
| Long term investments | 3497.00M | 5495.00M | 6987.00M | 7338.00M | 6851.00M |
| Net tangible assets | -23302.00000M | 26316.00M | 1465.00M | 20638.00M | 23510.00M |
| Short term investments | 11.00M | 1114.00M | - | - | - |
| Net receivables | 5381.00M | 5017.00M | 5663.00M | 7132.00M | 7226.00M |
| Long term debt | 8145.00M | 10615.00M | 7675.00M | 12203.00M | 11098.00M |
| Inventory | 8257.00M | 8353.00M | 8159.00M | 9451.00M | 9333.00M |
| Accounts payable | 12635.00M | 11255.00M | 11136.00M | 14458.00M | 14341.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 4091.00M | 402.00M | 498.00M | 641.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -2993.00000M | -2805.00000M | -2109.00000M | -3771.00000M | -3897.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 12.00M | 12.00M | 12.00M | 12.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 37801.00M | 35121.00M | 34210.00M | 35815.00M |
| Treasury stock | - | -20683.00000M | -20593.00000M | -20575.00000M | -19057.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 2553.00M | 287.00M | 137.00M | -822.00000M | 10225.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 81125.00M | 73222.00M | 65471.00M | 69101.00M | 48899.00M |
| Capital lease obligations | 24471.00M | 23803.00M | 24412.00M | 24399.00M | - |
| Long term debt total | - | 10615.00M | 7675.00M | 12203.00M | 11098.00M |
| Breakdown | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Investments | -3094.00000M | -1064.00000M | 4072.00M | -1297.00000M | 3.00M |
| Change to liabilities | 1243.00M | 192.00M | 842.00M | 746.00M | 20.00M |
| Total cashflows from investing activities | -3094.00000M | -1064.00000M | 4072.00M | -1297.00000M | -2307.00000M |
| Net borrowings | -2703.00000M | 1996.00M | -7127.00000M | -1208.00000M | 2508.00M |
| Total cash from financing activities | -887.00000M | -1499.00000M | -9036.00000M | -4647.00000M | -3047.00000M |
| Change to operating activities | 5401.00M | -73.00000M | 712.00M | 961.00M | -640.00000M |
| Net income | -3528.00000M | 4065.00M | 2512.00M | 424.00M | 3962.00M |
| Change in cash | -1702.00000M | 1288.00M | 524.00M | -461.00000M | 232.00M |
| Begin period cash flow | 2558.00M | 1270.00M | 746.00M | 1207.00M | 975.00M |
| End period cash flow | 856.00M | 2558.00M | 1270.00M | 746.00M | 1207.00M |
| Total cash from operating activities | 2258.00M | 3899.00M | 5555.00M | 5484.00M | 5594.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 2257.00M | 1990.00M | 1973.00M | 1927.00M | 2038.00M |
| Other cashflows from investing activities | 6336.00M | 669.00M | 1355.00M | 77.00M | -608.00000M |
| Dividends paid | 1659.00M | 1659.00M | 1617.00M | 1747.00M | 1643.00M |
| Change to inventory | 287.00M | -433.00000M | 165.00M | 63.00M | 141.00M |
| Change to account receivables | 72.00M | 808.00M | -1451.00000M | 163.00M | -789.00000M |
| Sale purchase of stock | -150.00000M | -187.00000M | -110.00000M | -1589.00000M | -4160.00000M |
| Other cashflows from financing activities | 3580.00M | 8707.00M | -3928.00000M | -158.00000M | 74.00M |
| Change to netincome | -4363.00000M | -75.00000M | 612.00M | 2192.00M | 521.00M |
| Capital expenditures | 2117.00M | 1734.00M | 1379.00M | 1374.00M | 1702.00M |
| Change receivables | - | 808.00M | -1451.00000M | 163.00M | -789.00000M |
| Cash flows other operating | - | -2648.00000M | -46.00000M | -31.00000M | -299.00000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | 1336.00M | 591.00M | -460.00000M | 240.00M |
| Change in working capital | 7444.00M | 495.00M | 428.00M | 941.00M | -740.00000M |
| Stock based compensation | 385.00M | 391.00M | 155.00M | 137.00M | 119.00M |
| Other non cash items | -1929.00000M | -2676.00000M | 254.00M | 2098.00M | 115.00M |
| Free cash flow | 141.00M | 2165.00M | 4176.00M | 4110.00M | 3892.00M |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance Inc |
0.42 4.62% | 9.62 | - | 5.40 | 0.11 | 1.14 | 0.33 | -4.3066 |
| RADLY Raia Drogasil SA ADR |
0.12 3.86% | 3.23 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBHF Alibaba Health Information Technology Limited |
0.005 1.14% | 0.45 | 50.80 | 29.59 | 0.30 | 3.62 | 1.58 | 34.83 |
| ALBBY Alibaba Health Information Technology Limited |
0.04 0.50% | 8.98 | 48.10 | 30.30 | 0.29 | 3.70 | 1.58 | 34.83 |
| SHPPF Shop Apotheke Europe N.V |
-20.84 13.03% | 139.16 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
108 Wilmot Road, Deerfield, IL, United States, 60015
| Name | Title | Year Born |
|---|---|---|
| Mr. Stefano Pessina | Exec. Chairman | 1941 |
| Ms. Rosalind Gates Brewer | CEO & Director | 1962 |
| Mr. James Kehoe | Exec. VP & Global CFO | 1962 |
| Ms. Ornella Barra | Chief Operating Officer of International | 1953 |
| Mr. Hsiao Wang | Sr. VP & Chief Information Officer | 1973 |
| Mr. Gerald Gradwell | Sr. VP of Investor Relations | 1968 |
| Ms. Danielle Carim Gray | Exec. VP & Global Chief Legal Officer | 1979 |
| Mr. Aaron C. Radelet | Global Chief Communications Officer & Sr. VP | NA |
| Ms. Holly May | Exec. VP & Global Chief HR Officer | 1982 |
| Ms. Mia M. Scholz | Sr. VP of Corp. Financial Operations | 1966 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...